Open AccessFeasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer
Author(s) -
Yoshihisa Shimada,
Kenji Suzuki,
Morihito Okada,
Haruhiko Nakayama,
Hiroyuki Ito,
Tetsuya Mitsudomi,
Hisashi Saji,
Kazuya Takamochi,
Yujin Kudo,
Aritoshi Hattori,
Takahiro Mimae,
Keiju Aokage,
Teppei Nishii,
Masahiro Tsuboi,
Norihiko Ikeda
Publication year - 2016
Publication title -
interactive cardiovascular and thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 56
eISSN - 1569-9293
pISSN - 1569-9285
DOI - 10.1093/icvts/ivw245
Subject(s) - medicine , pneumonectomy , radiation therapy , chemoradiotherapy , surgery , lung cancer , perioperative , stage (stratigraphy) , salvage therapy , chemotherapy , oncology , biology , paleontology
For highly selected patients with Stage III non-small-cell lung cancer (NSCLC) who relapse or have residual disease after definitive chemoradiotherapy, salvage lung resection is likely to be one of the options for local control and possible better prognosis. However, the long-term benefit has not been verified.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom